Chiara Cerrato

1.8k total citations
18 papers, 353 citations indexed

About

Chiara Cerrato is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Chiara Cerrato has authored 18 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Hematology and 8 papers in Oncology. Recurrent topics in Chiara Cerrato's work include Multiple Myeloma Research and Treatments (13 papers), Protein Degradation and Inhibitors (9 papers) and Peptidase Inhibition and Analysis (5 papers). Chiara Cerrato is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Protein Degradation and Inhibitors (9 papers) and Peptidase Inhibition and Analysis (5 papers). Chiara Cerrato collaborates with scholars based in Italy, United Kingdom and United States. Chiara Cerrato's co-authors include Antonio Palumbo, Francesca Gay, Julie Ahringer, Mario Boccadoro, Roberto Mina, Dong Yan, Mattia D’Agostino, Jürgen Jänes, Jacques Serizay and Alex Appert and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Genome Research.

In The Last Decade

Chiara Cerrato

18 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Cerrato Italy 11 274 180 103 73 45 18 353
Yusuke Tarumoto Japan 10 371 1.4× 83 0.5× 50 0.5× 30 0.4× 64 1.4× 32 468
Anne-Gaëlle Rio France 8 386 1.4× 79 0.4× 41 0.4× 14 0.2× 44 1.0× 11 486
Alice Can Ran Qin United States 5 218 0.8× 38 0.2× 81 0.8× 27 0.4× 6 0.1× 7 318
Jon Kerry United Kingdom 8 405 1.5× 103 0.6× 24 0.2× 6 0.1× 55 1.2× 9 471
Svenja Leible Germany 7 366 1.3× 54 0.3× 88 0.9× 10 0.1× 16 0.4× 10 509
Simona Segalla Italy 9 569 2.1× 187 1.0× 39 0.4× 5 0.1× 18 0.4× 9 610
Helga Seyschab Germany 10 307 1.1× 39 0.2× 102 1.0× 18 0.2× 38 0.8× 12 389
Caila Ryan United States 9 385 1.4× 38 0.2× 67 0.7× 5 0.1× 15 0.3× 9 456
Sandeep N. Wontakal United States 9 309 1.1× 46 0.3× 28 0.3× 4 0.1× 71 1.6× 13 371
Fabienne Schmit Germany 6 385 1.4× 9 0.1× 179 1.7× 13 0.2× 41 0.9× 6 445

Countries citing papers authored by Chiara Cerrato

Since Specialization
Citations

This map shows the geographic impact of Chiara Cerrato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Cerrato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Cerrato more than expected).

Fields of papers citing papers by Chiara Cerrato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Cerrato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Cerrato. The network helps show where Chiara Cerrato may publish in the future.

Co-authorship network of co-authors of Chiara Cerrato

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Cerrato. A scholar is included among the top collaborators of Chiara Cerrato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Cerrato. Chiara Cerrato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cerrato, Chiara, et al.. (2022). Widespread transposon co-option in the Caenorhabditis germline regulatory network. Science Advances. 8(50). eabo4082–eabo4082. 6 indexed citations
2.
Appert, Alex, Chiara Cerrato, Ni Huang, et al.. (2021). DREAM represses distinct targets by cooperating with different THAP domain proteins. Cell Reports. 37(3). 109835–109835. 10 indexed citations
3.
Serizay, Jacques, Dong Yan, Jürgen Jänes, et al.. (2020). Distinctive regulatory architectures of germline-active and somatic genes in C. elegans. Genome Research. 30(12). 1752–1765. 31 indexed citations
4.
Beltran, Toni, Consuelo Barroso, Lewis Stevens, et al.. (2019). Comparative Epigenomics Reveals that RNA Polymerase II Pausing and Chromatin Domain Organization Control Nematode piRNA Biogenesis. Developmental Cell. 48(6). 793–810.e6. 30 indexed citations
5.
Gay, Francesca, Chiara Cerrato, Maria Teresa Petrucci, et al.. (2019). Efficacy of carfilzomib lenalidomide dexamethasone (KRd) with or without transplantation in newly diagnosed myeloma according to risk status: Results from the FORTE trial.. Journal of Clinical Oncology. 37(15_suppl). 8002–8002. 62 indexed citations
6.
Jänes, Jürgen, Dong Yan, Michael Schoof, et al.. (2018). Chromatin accessibility dynamics across C. elegans development and ageing. eLife. 7. 62 indexed citations
7.
Bonello, Francesca, et al.. (2018). CD38 as an immunotherapeutic target in multiple myeloma. Expert Opinion on Biological Therapy. 18(12). 1209–1221. 30 indexed citations
8.
Foà, Robin, Pellegrino Musto, Chiara Cerrato, et al.. (2018). Updated efficacy data and MRD analysis according to risk status in newly diagnosed myeloma patients treated with carfilzomib + lenalidomide or cyclophosphamide (FORTE trial).. Journal of Clinical Oncology. 36(15_suppl). 8009–8009. 3 indexed citations
9.
Mina, Roberto, Mattia D’Agostino, Chiara Cerrato, Francesca Gay, & Antonio Palumbo. (2016). Plasma cell leukemia: update on biology and therapy. Leukemia & lymphoma. 58(7). 1538–1547. 31 indexed citations
10.
Mina, Roberto, et al.. (2015). New pharmacotherapy options for multiple myeloma. Expert Opinion on Pharmacotherapy. 17(2). 181–192. 12 indexed citations
11.
Cerrato, Chiara, Roberto Mina, & Antonio Palumbo. (2013). Optimal management of elderly patients with myeloma. Expert Review of Anticancer Therapy. 14(2). 217–228. 6 indexed citations
12.
Cerrato, Chiara & Antonio Palumbo. (2013). Initial Treatment of Nontransplant Patients With Multiple Myeloma. Seminars in Oncology. 40(5). 577–584. 6 indexed citations
13.
Bringhen, Sara, et al.. (2013). The mechanism of action, pharmacokinetics, and clinical efficacy of carfilzomib for the treatment of multiple myeloma. Expert Opinion on Drug Metabolism & Toxicology. 9(10). 1371–1379. 16 indexed citations
14.
Cerrato, Chiara, Maria Teresa Petrucci, Mariella Genuardi, et al.. (2013). A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma. Blood. 122(21). 685–685. 7 indexed citations
15.
Palumbo, Antonio, Roberto Mina, Chiara Cerrato, & Federica Cavallo. (2013). Role of Consolidation/Maintenance Therapy in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 13. S349–S354. 6 indexed citations
16.
Palumbo, Antonio & Chiara Cerrato. (2013). Diagnosis and therapy of multiple myeloma. The Korean Journal of Internal Medicine. 28(3). 263–263. 15 indexed citations
17.
Bringhen, Sara, et al.. (2012). Evaluation of the pharmacokinetics, preclinical, and clinical efficacy of lenalidomide for the treatment of multiple myeloma. Expert Opinion on Drug Metabolism & Toxicology. 8(9). 1209–1222. 9 indexed citations
18.
Palumbo, Antonio, Sara Galimberti, Oreste Villani, et al.. (2012). Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) for Newly Diagnosed Multiple Myeloma (MM) Patients. Blood. 120(21). 730–730. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yusuke Tarumoto Breakdown of academic impact, for papers by Anne-Gaëlle Rio Breakdown of academic impact, for papers by Alice Can Ran Qin Breakdown of academic impact, for papers by Jon Kerry Breakdown of academic impact, for papers by Svenja Leible Breakdown of academic impact, for papers by Simona Segalla Breakdown of academic impact, for papers by Helga Seyschab Breakdown of academic impact, for papers by Caila Ryan Breakdown of academic impact, for papers by Sandeep N. Wontakal Breakdown of academic impact, for papers by Fabienne Schmit
Rankless by CCL
2026